Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Divi's Laboratories slumps as quarterly profit falls

** Shares of Indian pharmaceutical company Divi's
Laboratories  DIVI.NS  fall as much as 7.8% to 3,455.05 rupees,
in their biggest intra-day pct loss since May 23
    ** DIVI on Monday reported a drop of 18.5% in quarterly
profit to 4.94 bln rupees ($60.05 mln)  urn:newsml:reuters.com:*:nFWN32203N
    ** Rev from ops stood at 18.55 bln rupees vs 19.88 bln
rupees a yr ago  
    ** Stock falls for a second consecutive session
    ** DIVI top pct loser on India's Nifty Pharma Index
 .NIPHARM 
    ** More than 1 mln shares change hands by 0740 GMT, 2.1x
30-day avg of 484,549 shares
    ** 12 of the 21 analysts covering the stock have a "buy" or
"strong buy" rating, three have "hold" while six rate it at
"sell" or "strong sell"; median PT is 4,173 rupees - Refinitiv
data
    ** Stock down 19.9% so far this year as of last close, vs a
5.6% fall in the Nifty Pharma index
($1 = 82.2700 Indian rupees)
 (Reporting by Atreya Raghavan in Bengaluru)
 ((Atreya.Raghavan@thomsonreuters.com; Mobile: +91 8527959656))

Recent news on Divi's Laboratories

See all news